Source link : https://newshealth.biz/health-news/saroglitazar-boosts-response-rates-in-primary-biliary-cholangitis/
Novel saroglitazar significantly improved biochemical response rates in patients with primary biliary cholangitis (PBC) who had an inadequate response to ursodeoxycholic acid or couldn’t tolerate it, according to the EPICS-III randomized clinical trial. Among 148 patients, 56.7% of those randomized to oral saroglitazar (55 of 97) had a biochemical response at 52 weeks compared with […]
The post Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-01 17:53:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8